Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Granted symbols : NVAX save search
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and Older
Published: 2022-09-12 (Crawled : 14:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.98%
H: 3.22%
C: 3.03%
covid-19 vaccine granted authorization
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17
Published: 2022-08-26 (Crawled : 14:20) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.03%
H: 1.53%
C: -5.48%
covid-19 vaccine granted authorization
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17
Published: 2022-08-18 (Crawled : 14:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: -6.47%
covid-19 vaccine granted approval
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
Published: 2022-08-17 (Crawled : 13:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -1.82%
H: 1.31%
C: -6.48%
covid-19 vaccine granted approval
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17
Published: 2022-07-26 (Crawled : 12:20) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.2%
H: 6.0%
C: 2.08%
covid-19 australia vaccine granted
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: -0.2%
H: 3.78%
C: 1.16%
covid-19 approval covid vaccine grant granted
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Published: 2022-01-19 (Crawled : 01:00) - prnewswire.com
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 2.59%
H: 3.89%
C: -4.6%
covid-19 covid tga australia vaccine granted grant
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
Published: 2021-12-17 (Crawled : 18:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 15.03%
H: 0.0%
C: 0.0%
covid-19 health covid india vaccine merge nvx-cov2373 granted grant
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.